Biogen Idec (NQ:BIIB)
Price and Volume
Detailed Quote| Volume | 163 |
| Open | 232.83 |
| Bid (Size) | 235.50 (100) |
| Ask (Size) | 236.80 (200) |
| Prev. Close | 232.83 |
| Today's Range | 232.83 - 232.83 |
| 52wk Range | 138.00 - 238.24 |
| Shares Outstanding | 146,800,000 |
| Dividend Yield | N/A |
Top News
More News
Discover which S&P500 stocks are making waves on Monday. ↗
October 12, 2026
Performance
52-Week Range
2.3% below 52-week high
232.83
138.0052W Low
238.2452W High
1 Week
2.3% below 1-week high
215.731W Low
238.241W High
Biogen Idec (BIIB) traded between $138.00 and $238.24 over the past 52 weeks and last traded at $232.83, 2.3% below its 52-week high. Over the past week it ranged between $215.73 and $238.24.
Past 12 Months
1W
+$14.40
1M
+$15.47
3M
+$35.59
6M
+$52.29
YTD
+$55.01
1Y
+$87.52
BIIB was +60.2% over the past year, +29.0% over six months, +30.9% year to date, +6.6% in the last week.
12 Months vs Market
BIIB
+60.2%
DIA
+11.4%
SPY
+16.2%
QQQ
+21.9%
IWM
+9.5%
Over the past 12 months BIIB returned +60.2% versus DIA (Dow) +11.4%, SPY (S&P 500) +16.2%, QQQ (Nasdaq 100) +21.9% and IWM (Russell 2000) +9.5%.
Volume & Liquidity
0.00× 3-mo avg
Today 163
3-mo avg 1.0M
1W
1.3M
1M
1.2M
3M
1.0M
6M
1.1M
YTD
1.2M
1Y
1.4M
BIIB most recently traded 163 shares against a 3-month average daily volume of 1.0M.
More News
Read More
2 Surging Stocks for Long-Term Investors and 1 We Brush Off
October 12, 2026
Therapeutics Stocks Q2 Highlights: Gilead Sciences (NASDAQ:GILD)
October 07, 2026
1 Profitable Stock Worth Investigating and 2 We Ignore
October 01, 2026
Biogen (NASDAQ:BIIB) Q2 Earnings: Leading The Therapeutics Pack
September 24, 2026
Reflecting On Therapeutics Stocks’ Q2 Earnings: AbbVie (NYSE:ABBV)
September 21, 2026
Biogen Eyes Wave of Phase III Readouts as It Expands Beyond Neuroscience ↗
September 15, 2026
Biogen Sees Pivotal Pipeline Moment as It Expands Beyond Neurology ↗
September 12, 2026
Thursday's session: top gainers and losers in the S&P500 index ↗
September 10, 2026
A Micro-Cap Biotech Just Cleared a Milestone Most Never Reach
September 08, 2026
A Micro-Cap Biotech Just Cleared a Milestone Most Never Reach
September 08, 2026
Therapeutics Stocks Q2 Recap: Benchmarking Myriad Genetics (NASDAQ:MYGN)
September 07, 2026
Frequently Asked Questions
Is Biogen Idec publicly traded?
Yes, Biogen Idec is publicly traded.
What exchange does Biogen Idec trade on?
Biogen Idec trades on the Nasdaq Stock Market
What is the ticker symbol for Biogen Idec?
The ticker symbol for Biogen Idec is BIIB on the Nasdaq Stock Market
What is the current price of Biogen Idec?
The current price of Biogen Idec is 232.83
When was Biogen Idec last traded?
The last trade of Biogen Idec was at 10/14/26 04:00 PM ET
What is the market capitalization of Biogen Idec?
The market capitalization of Biogen Idec is 34.18B
How many shares of Biogen Idec are outstanding?
Biogen Idec has 34B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.